Lipid macropinocytosis: a novel target in atherosclerotic cardiovascular disease

脂质巨胞饮作用:动脉粥样硬化性心血管疾病的新靶点

基本信息

  • 批准号:
    10401923
  • 负责人:
  • 金额:
    $ 38.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-07-01 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

Project Summary Atherosclerosis, the main underlying cause of death worldwide, is characterized by chronic inflammation and accumulation of lipids in the arterial wall. Excessive lipid accumulation by macrophages (MΦs) and vascular smooth muscle cells (SMCs) plays a key role in the initiation and progression of atherosclerosis. It is generally accepted that atherosclerosis arise from LDL modification in the arterial wall and its subsequent internalization by MΦs and SMCs through a variety of scavenger receptors. The role of scavenger receptor-independent lipid uptake in atherosclerosis, the physiological factors stimulating this process, and the signaling mechanisms involved remain poorly characterized. We reported that matrix protein thrombospondin-1 (TSP1) stimulates direct, scavenger receptor-independent uptake of unmodified, native LDL (nLDL) in MΦs. TSP1 via its cognate receptor CD47 activates actin-binding protein cofilin, leading to macropinocytosis of nLDL, and excessive cholesterol accumulation. The signaling mechanisms downstream of CD47 that stimulate macropinocytosis are unknown. Although phospholipase C (PLC) and slingshot phosphatase 1 (SSH1) have been shown to activate cofilin, their roles in TSP1-induced macropinocytosis have not yet been investigated. Moreover, the ability of TSP1-CD47 signaling to stimulate MΦ macropinocytosis in atherosclerotic vessels in vivo and the significance of lipid macropinocytosis in the pathogenesis of atherosclerosis remain to be determined. Our novel preliminary data show that TSP1 and CD47 knockout mice are protected from atherosclerosis and the macropinocytosis inhibitor EIPA decreases atherosclerotic lesion formation in hypercholesterolemic mice. We hypothesize that TSP1 via CD47 promotes lipid macropinocytosis in the arterial wall, contributing to lipid accumulation and the pathogenesis of atherosclerosis. The hypothesis will be tested via the following aims: (1) examining for the first time whether CD47 receptor signaling in MΦs stimulates macropinocytosis via PLC- and SSH1-mediated cofilin activation and contributes to atherosclerosis development; (2) exploring whether MΦs internalize lipoproteins via macropinocytosis in atherosclerotic arteries in vivo and that deletion of NHE1 (major target of EIPA) specifically in MΦs attenuates atherosclerosis, and (3) investigating whether TSP1 binding to CD47 stimulates macropinocytosis in MΦ-like SMCs via Nox1-mediated cofilin activation. The proposal will employ global and cell-specific knockout mice, and other genetic tools to test the hypothesis. Specific targeting of CD47 via multiple approaches (antibody blockade, siRNA/morpholino silencing, and CD47 activating peptide sequences) will provide confirmation of results obtained in genetic mutants. Multiple complementary techniques will be used to study macropinocytosis in vitro (pharmacological, genetic, fluorescence/high-resolution microscopy) and in vivo (cofilin mutants, AngioSPARK 680, MΦ-specific NHE1 knockouts). This innovative proposal has the potential to reveal important new mechanisms of lipid internalization and provide a paradigm shift in our knowledge about how atherosclerosis develops.
项目总结

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
PKCδ stimulates macropinocytosis via activation of SSH1-cofilin pathway.
  • DOI:
    10.1016/j.cellsig.2018.09.018
  • 发表时间:
    2019-01
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Singla B;Lin HP;Ghoshal P;Cherian-Shaw M;Csányi G
  • 通讯作者:
    Csányi G
Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.
Sildenafil improves vascular endothelial function in patients with cystic fibrosis.
  • DOI:
    10.1152/ajpheart.00301.2018
  • 发表时间:
    2018-11
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Paula Rodriguez-Miguelez;N. Lee;M. Tucker;G. Csányi;K. McKie;C. Forseen;R. Harris
  • 通讯作者:
    Paula Rodriguez-Miguelez;N. Lee;M. Tucker;G. Csányi;K. McKie;C. Forseen;R. Harris
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gabor Csanyi其他文献

Gabor Csanyi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gabor Csanyi', 18)}}的其他基金

SMC macropinocytosis: a novel target in atherosclerotic vascular disease
SMC巨胞饮作用:动脉粥样硬化性血管疾病的新靶点
  • 批准号:
    10735697
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
  • 项目类别:
Lipid macropinocytosis: a novel target in atherosclerotic cardiovascular disease
脂质巨胞饮作用:动脉粥样硬化性心血管疾病的新靶点
  • 批准号:
    10172967
  • 财政年份:
    2018
  • 资助金额:
    $ 38.5万
  • 项目类别:
A Novel Role of Macrophage TSP1-CD47 Signaling in Atherosclerosis
巨噬细胞 TSP1-CD47 信号传导在动脉粥样硬化中的新作用
  • 批准号:
    9071987
  • 财政年份:
    2015
  • 资助金额:
    $ 38.5万
  • 项目类别:
A Novel Role of Macrophage TSP1-CD47 Signaling in Atherosclerosis
巨噬细胞 TSP1-CD47 信号传导在动脉粥样硬化中的新作用
  • 批准号:
    9294101
  • 财政年份:
    2015
  • 资助金额:
    $ 38.5万
  • 项目类别:
A Novel Role of Macrophage TSP1-CD47 Signaling in Atherosclerosis
巨噬细胞 TSP1-CD47 信号传导在动脉粥样硬化中的新作用
  • 批准号:
    9094734
  • 财政年份:
    2015
  • 资助金额:
    $ 38.5万
  • 项目类别:
A Novel Role of Macrophage TSP1-CD47 Signaling in Atherosclerosis
巨噬细胞 TSP1-CD47 信号传导在动脉粥样硬化中的新作用
  • 批准号:
    8579966
  • 财政年份:
    2013
  • 资助金额:
    $ 38.5万
  • 项目类别:
A Novel Role of Macrophage TSP1-CD47 Signaling in Atherosclerosis
巨噬细胞 TSP1-CD47 信号传导在动脉粥样硬化中的新作用
  • 批准号:
    8725727
  • 财政年份:
    2013
  • 资助金额:
    $ 38.5万
  • 项目类别:

相似海外基金

Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
  • 批准号:
    10549640
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
  • 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
  • 批准号:
    2750554
  • 财政年份:
    2021
  • 资助金额:
    $ 38.5万
  • 项目类别:
    Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
  • 批准号:
    61319
  • 财政年份:
    2020
  • 资助金额:
    $ 38.5万
  • 项目类别:
    Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10013588
  • 财政年份:
    2020
  • 资助金额:
    $ 38.5万
  • 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
  • 批准号:
    20K07009
  • 财政年份:
    2020
  • 资助金额:
    $ 38.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
  • 批准号:
    10603473
  • 财政年份:
    2020
  • 资助金额:
    $ 38.5万
  • 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
  • 批准号:
    2342674
  • 财政年份:
    2020
  • 资助金额:
    $ 38.5万
  • 项目类别:
    Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
  • 批准号:
    10117194
  • 财政年份:
    2020
  • 资助金额:
    $ 38.5万
  • 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10115604
  • 财政年份:
    2020
  • 资助金额:
    $ 38.5万
  • 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
  • 批准号:
    10294224
  • 财政年份:
    2018
  • 资助金额:
    $ 38.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了